Search results
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 4 days agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 4 days agoWithin minutes of getting the Johnson & Johnson Covid-19 vaccine, Michelle Zimmerman felt pain...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 4 days agoModerna’s next focus is to continue rolling out mRNA vaccines, which teaches cells how to make the...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 5 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 9 hours agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 4 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 4 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 5 days agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 5 days agos first-quarter expectations Thursday. The Covid vaccine maker came out of the March quarter with a...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 10 hours agoModerna, a commercial-stage biotech founded in 2010 and publicly traded since December 2018, swiftly validated its mRNA technology with the release of its COVID< ...